Drug quality control labs in Bolivia, Peru and Uruguay prequalified by PAHO/WHO

15 September 2010

The national Laboratories for the Quality Control of Medicines in Bolivia, Peru and Uruguay have been prequalified by the Pan American Health Organization and the World Health Organization to serve as "International Reference Laboratories for the Agencies of the United Nations."

CONCAMYT, the National Laboratory for Quality Control of Medicines in Bolivia, the National Center for Quality Control-CNCC in Peru and the Commission for Quality Control of Medicines-CCCM in Uruguay have completed all stages of the prequalification process established by PAHO/WHO and have been incorporated in the reference list of quality control laboratories for medicines that PAHO/WHO provides for UN agencies.

The three prequalified laboratories participate actively in the Regional Network of Quality Control Laboratories in the Americas, an initiative coordinated by the Medicines and Health Technologies project at PAHO in order to strengthen the capacity of quality control laboratories within national health systems. The international reference laboratories also perform an important role in the quality monitoring of the medicines purchased through international organizations such as PAHO/WHO, the Global Fund, UNAIDS, UNICEF, the Red Cross, Clinton Foundation, among others.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical